VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
84,914
AK1,768
AL5,988
AR3,891
AS44
AZ14,245
CA63,267
CO11,909
CT8,556
DC1,717
DE1,825
FL40,527
FM3
GA15,029
GU90
HI2,403
IA4,648
ID2,681
IL21,021
IN23,404
KS4,710
KY8,050
LA5,205
MA15,004
MD12,861
ME3,217
MH8
MI19,677
MN12,494
MO9,831
MP30
MS2,995
MT2,334
NC17,007
ND1,410
NE2,973
NH3,077
NJ19,053
NM4,017
NV4,506
NY35,670
OH19,699
OK6,387
OR8,726
PA24,488
PR2,386
QM2
RI2,054
SC6,776
SD1,217
TN9,725
TX37,771
UT4,390
VA15,128
VI61
VT1,759
WA15,121
WI11,313
WV2,399
WY878
XB5
XL1
XV2

ID: 0946021
Sex: F
Age:
State: CA

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever (101.5?); chills; muscle aches; nausea; This is a spontaneous report from a contactable Nurse (patient). A 22-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL1284), intramuscularly on 07Jan2021 at single dose for covid-19 immunization. Vaccine location was right arm and it was the second dose. The facility type vaccine was hospital. Patient Intramuscularly received the first dose of BNT162B2 on 17Dec2020 (lot number EH9899) at arm left. Patient is not pregnant. The patient medical history and concomitant medications were not reported. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever (101.5?), chills, muscle aches, nausea on 08Jan2021 with outcome of recovered in Jan2021. Patient didn't receive treatment for the adverse events. The events were reported as non-serious.

Other Meds:

Current Illness:

ID: 0946022
Sex: F
Age:
State: WA

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchiness (like something crawling in my face and extremities) all over intermittently lasted 2 days; This is a spontaneous report from a contactable nurse. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration, at the left arm on 23Dec2020 09:30 at single dose for COVID-19 immunization at a hospital. Medical history included dry eyes, carcinoma in situ, and procedure of complete hysterectomy. The patient was not pregnant at the time of vaccination. Concomitant medications included camellia sinensis extract (GREEN TEA), ciclosporin (RESTASIS), estradiol (VIVELLE DOT). The patient previously took augmentin and experienced allergies. The patient experienced itchiness (like something crawling in my face and extremities) all over intermittently lasted 2 days on 23Dec2020 09:30 and was treated with cetirizine hydrochloride (ZYRTEC) x1 on the second day. The patient recovered from the event on 25Dec2020.

Other Meds: GREEN TEA [CAMELLIA SINENSIS EXTRACT]; RESTASIS; VIVELLE DOT

Current Illness:

ID: 0946023
Sex: F
Age:
State: NY

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shivering; tachycardia; BP 139/89/BP 148/91; Left arm very sore; Left arm tingled; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 53-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 07Jan2021 10:30 in left arm at single dose for COVID-19 immunization. Medical history included mild hypertension, chronic migraine and recent elevated liver tests - Alk Phos (alkaline phosphatase) & GGT (Gamma-glutamyltransferase) from an unknown date and unknown if ongoing. Concomitant medication included metoprolol succinate 25 mgs daily and colecalciferol (VITAMIN D). On 07Jan2021 21:30, following shot for a few minutes, the patient experienced left arm tingled, had a brief period lasting a few minutes of shivering that evening and tachycardia. Noted at 9:30 pm, patient's BP 139/89, pulse 88 (BP 115/88 and pulse 76 4 days prior). Then BP 148/91, pulse 69 at 10 am on 08Jan2021 after two doses of Metoprolol Succinate ER 25 mgs at 9:45 pm on 07Jan2021 and at 8:30 am on 08Jan2021. The patient experienced left arm very sore on 07Jan2021 after receiving vaccine. Seems to be improving on 08Jan2021. The outcome of the events was not recovered. no treatment was given to the patient for the events. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Other Meds: ; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0946024
Sex: F
Age:
State:

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; Dry mouth; Low grade fever; Chills; Headache; Itchy rash at injection site; Itchy rash at injection site; Soreness at injection site; This is a spontaneous report from a non-contactable nurse (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1685), via an unspecified route of administration on 31Dec2020 12:45 at left arm, at single dose for covid-19 immunization. Medical history known allergies: penicillin, chocolate from an unknown date. Concomitant medication included acetylsalicylic acid (ASPIRIN) and Birth control pills. The patient previously took erythromycin and known allergies: Erythromycin. The patient was not pregnant at the time of vaccination. The patient experienced fatigue, dry mouth, low grade fever, chills, headache, itchy rash at injection site, soreness at injection site on 31Dec2020 15:00. No treatment was received for all events. The outcome of the events was recovered on an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect. No follow up attempts are possible. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 0946025
Sex: F
Age:
State: MI

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: low grade fever, 99 degrees Fahrenheit starting the day following injection, lasting 1 day; Fatigue, moderate, lasting 1 day; Headache, moderate, lasting 1 day; This is a spontaneous report from a contactable consumer. A 26-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date unknown) at the hospital, via an unspecified route of administration on 28Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. On 28Dec2020, the patient experienced fatigue, moderate, lasting 1 day, headache, moderate, lasting 1 day, and low grade fever, 99 degrees Fahrenheit starting the day following injection, lasting 1 day. The events were considered as non-serious. No treatment was received for the events. It was unknown if patient was diagnosed with COVID-19 prior to vaccination. It was also unknown if patient has been tested for COVID-19 since the vaccination. The events recovered on 29Dec2020. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0946026
Sex: F
Age:
State: PA

Vax Date: 12/22/2020
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; body aches; fatigue; This is a spontaneous report from a contactable nurse. A 48-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 22Dec2020 11:30 to 22Dec2020 11:30 at a single dose for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient previously took aspirin, erythromycin, vancomycin and cipro; all experienced allergies. The patient had fever, body aches and fatigue on 01Jan2021. The outcome of the events was recovered in Jan2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946027
Sex: U
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscle aches; joint aches; lethargy; soreness at injection site; under the weather; This is a spontaneous report from a contactable other healthcare professional (patient). A 31-year-old patient of unspecified gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date unknown), via an unspecified route of administration on 08Jan2021 at 19:30 on Arm left at single dose for COVID-19 immunization. Medical history included Hypertension. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications included Fluoxetine, Amlodipine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took venlafaxine and experienced allergy. The patient experienced Muscle aches, joint aches, lethargy, soreness at injection site, under the weather on 09Jan2021 at 19:30. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ;

Current Illness:

ID: 0946028
Sex: F
Age:
State: NJ

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: the skin overlying the injection site has an intense prickly "itchy" sensation; left side of my face felt heavy, stiff, and was palpably warmer than the right side of my face; left side of my face felt heavy, stiff, and was palpably warmer than the right side of my face; I had a short episode of disequilibrium; awoken by intense bilateral leg pain; my legs felt weak the following day; This is a spontaneous report from a contactable Physician who reported for herself. A 49-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EK9231) for COVID-19 immunisation on 07Jan2021 at 15:30 at single dose in Left arm. Medical history included allergy to penicillin , clindamycin, azathioprine (IMURAN) (known allergies: penicillin, clindamycin, Imuran) , allergy to glove powder and autoimmune disorder (unspecified). Concomitant medication (received within 2 weeks of vaccination) included hydroxychloroquine sulfate (PLAQUENIL), methotrexate, mycophenolate mofetil (CELLCEPT), folic acid and magnesium. On 07Jan2021 at 17:30 , approximately 2 hours after she received the vaccine, she had a short episode of disequilibrium, then an hour after that (at 18.30) the left side of her face felt heavy, stiff and was palpably warmer than the right side of her face. There were no visible changes to the appearance of her face, and she had normal motor control. This episode lasted for approximately 1-2 hours then gradually diminished. In Jan202, approximately 36 hours after the vaccine, patient was awoken by intense bilateral leg pain. The pain gradually diminished after approximately an hour, but her legs felt weak the following day. Legs were fine on 10Jan2021. In the evening of 09Jan2021 though 10Jan2021, the skin overlying the injection site had an intense prickly "itchy" sensation, there was no rash. Events were all non serious. No treatment administered and final outcome for all the events was reported as recovering.

Other Meds: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; ; CELLCEPT [MYCOPHENOLATE MOFETIL]; ;

Current Illness:

ID: 0946029
Sex: F
Age:
State: KY

Vax Date: 12/17/2020
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; fast heart rate; low grade temp (99.4-100); headache; body aches; soreness at site; This is a spontaneous report from a contactable Nurse (patient herself). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Dec2020 13:00 (Lot number: EK5730) at SINGLE DOSE (first dose, left arm); and via an unspecified route of administration on 07Jan2021 13:00 (Lot number: EK9231) at SINGLE DOSE (second dose, left arm) for COVID-19 immunization. Medical history included hypertension, high cholesterol, Graves disease, and Known allergies: Sulfa from an unknown date and unknown if ongoing. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 since vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received the vaccine at hospital. Concomitant medication included hydrochlorothiazide, atorvastatin, amlodipine from unspecified dates for unspecified indications. The patient experienced nausea, fast heart rate, low grade temp (99.4-100), headache, body aches, soreness at site on 08Jan2021 06:00. The patient underwent lab tests and procedures which included temp 99.4-100 and heart rate fast on 08Jan2021. Treatment was not received for adverse events. Event outcome was recovering. The reporter assessed the events as non-serious.

Other Meds: ; ;

Current Illness:

ID: 0946030
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nausea; vomiting; chills; headache; This is a spontaneous report from a non-contactable nurse (patient). A 55-year-old female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot no: EL1283), via an unspecified route of administration on 07Jan2021 at 10:30 AM on the left arm at a single dose for COVID-19 immunization. Medical history included allergies to sulfa. The patient's concomitant medications were not reported. The patient previously received the first dose of (Pfizer-BioNTech COVID-19 mRNA vaccine, lot no: EJ1685) on 21Dec2020 at 10:00 AM on the left arm for COVID-19 immunization. The vaccine was administered in the hospital. The patient was not administered any other vaccine in four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The patient experienced nausea, vomiting, chills and headache on 07Jan2021 at 11:45 PM. The patient did not receive treatment for the events. The outcome of the events was recovering. The events were reported to be non-serious. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0946031
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bad headache; dizzy; weak; tired; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient who is a doctor had a bad headache, was dizzy, weak and tired after receiving the vaccine on an unknown date in Jan2021 with outcome of unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946032
Sex: F
Age:
State: PA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: funky lightheadedness; weird feelings in head; tinnitus was noticeably oscillated up and down; This is a spontaneous report from a contactable pharmacist. A 50-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: FK4176), intramuscularly on 07Jan2021 at 13:30 at a single dose on the left arm for COVID-19 immunization. Medical history was reported as none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and was not diagnosed with COVID-19 prior to vaccination. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730), intramuscularly on 17Dec2020 at 13:30 on the right arm for COVID-19 immunization and experienced funky lightheadedness, vertigo, normal tinnitus got louder and oscillating up and down, and sinus headache. Concomitant medication included colecalciferol (VITAMIN D). On 07Jan2021 at 13:30 (as reported), patient experienced funky lightheadedness, weird feelings in head, and tinnitus was noticeably oscillated up and down. The events were assessed as non-serious. The patient did not receive any treatment for the events. The patient was not pregnant at the time of vaccination. The outcome of the events was recovered on 07Jan2021 at 15:30.

Other Meds: VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0946033
Sex: F
Age:
State: TX

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; body ache; nausea; fatigue; ear pain; sweating; dizziness; This is a spontaneous report from a contactable other HCP (patient). A 41-year-old female patient (no pregnant) received first dose of BNT162B2 (Lot number= Ek5730) Intramuscular on 23Dec2020 00:30 AM (reported as 22Dec2020 12:30 PM) at single dose on Left arm for COVID-19 immunization. Medical history was Idiopathic Angiodema (Allergies). Concomitant drug included Levonorgestrel and ethinyl estradiol in two weeks. Adverse event reported as Headache, body ache, nausea, fatigue, ear pain x 2 days, sweating, dizziness (all non-serious) on 23Dec2020 09:00 AM. No treatment. No Covid prior vaccination. No covid tested post vaccination. NO any other vaccines within 4 weeks prior to the COVID vaccine.Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient was not been tested for COVID-19. Outcome of the event of ear pain was recovered on 25Dec2020, for other events was recovered. No follow-up attempts possible. No further information expected.

Other Meds: ; ETHINYL ESTRADIOL

Current Illness:

ID: 0946034
Sex: F
Age:
State: KY

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Chills; Swollen lymph node; exhaustion; fever; vomiting; This is a spontaneous report from a contactable consumer reported for self. This 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via unspecified route of administration on 08Jan2021 09:30 AM at single dose in right arm at nursing home/senior living facility for COVID-19 immunization. The patient is not pregnant. The patient medical history included known allergies: milk products, Crohn's disease. The patient did not have COVID prior vaccination. The patient concomitant mediations included bupropion hydrochloride (WELLBUTRIN XL), hydroxyzine. The patient did not receive vaccine in four weeks. The patient experienced headache, chills, swollen lymph node, exhaustion, fever, vomiting in Jan2021. The onset date of events was reported as "01Jan2021". The events were reported as non-serious by reporter. The patient did not test COVID post vaccination. The patient did not receive treatment. The outcome of events was not resolved. Information about lot/batch number has been requested.

Other Meds: WELLBUTRIN XL;

Current Illness:

ID: 0946035
Sex: F
Age:
State: NC

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mild itching throughout different parts of the body; This is a spontaneous report received from a contactable consumer (patient). A 76-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El3246), via an unspecified route of administration in left arm, on 07Jan2021 11:15 at single dose, for COVID-19 immunization, in a public health facility. Medical history included mitral valve prolapse, glaucoma, and allergy to strawberry. The patient is not pregnant. Concomitant medication included latanoprost; estradiol, norethisterone acetate (MIMVEY); multivitamins; and ergocalciferol (VIT D). The patient did not receive any vaccine within 4 weeks prior to COVID vaccine. The patient experienced mild itching throughout different parts of the body beginning on day 2, 09Jan2021 10:00, and continuing on day 5. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient has not been tested for COVID-19. The outcome of the event was not recovered. No follow up attempts are possible. No further information is expected.

Other Meds: ; MIMVEY; MULTIVITAMINS [VITAMINS NOS]; VIT D

Current Illness:

ID: 0946036
Sex: F
Age:
State: MI

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Insomnia; soreness at injection site; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248), via an unspecified route of administration on 09Jan2021 12:15 in left arm at single dose for COVID-19 immunization. Medical history included chronic sinusitis from an unknown date and unknown if ongoing. There were no concomitant medications. On 09Jan2021 12:45, the patient experienced chills, insomnia and soreness at injection site. No treatment was given to the patient for the events. The outcome of the events was recovering. The facility where the most recent COVID-19 vaccine was administered was in the Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events was considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Other Meds:

Current Illness:

ID: 0946037
Sex: F
Age:
State: PA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; dizziness; body ache; This is a spontaneous report from a contactable healthcare professional. A 24-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: PF13K9231), via an unspecified route of administration on the right arm on 09Jan2021 14:45 at single dose for COVID-19 immunisation. Medical history included bipolar 2, ADHD and obesity. Concomitant medication included sertraline, methylphenidate hydrochloride (RITALIN) and methylphenidate. The patient experienced nausea, dizziness and body ache on 09Jan2021 19:00. The patient received no treatment. The outcome of the events was recovering.

Other Meds: ; RITALIN;

Current Illness:

ID: 0946038
Sex: M
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High fever; chills; sweats; This is a spontaneous report from a contactable Other HCP (patient). A 41-year-old male patient received the second dose of BNT162B2 (Lot/batch number and expiry date unknown), via an unspecified route of administration on 08Jan2021 at single dose in the left arm for an unspecified indication. Medical history included high blood pressure and allergy to coconut. There were no concomitant medications. The patient previously took acetylsalicylic acid (ASPIRIN) and experienced allergies. Historical vaccine includes BNT162B2 received via intramuscular on 11Dec2020 14:00 ("also reported as 12Dec2020 14:00) at single dose (first dose) in the left arm for COVID-19 immunization. On 09Jan2021 07:00, the patient experienced high fever, chills and sweats. The patient did not receive any other vaccines within four weeks prior to the vaccination and did not receive other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The vaccine was given in the Hospital. The outcome of the events was not recovered. Information regarding lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946039
Sex: F
Age:
State: FL

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy rash/ hives neck area, trunk; Itchy rash/ hives neck area, trunk; This is a spontaneous report from a contactable consumer (patient) reported that a 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246, expiration date: not reported), via an unspecified route of administration on the left arm on 08Jan2021 11:00 at single dose for COVID-19 immunization. Medical history included psoriasis and allergies to Penicillin; both from unknown dates. The patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine and rosuvastatin calcium (CRESTOR) taken from unspecified dates for unspecified indications. On 08Jan2021, the patient experienced itchy rash/hives neck area, trunk with outcome of recovering. As treatment, patient received Benedryl (as reported). Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible; information about lot number was already obtained.

Other Meds: ; CRESTOR

Current Illness:

ID: 0946040
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: but then yesterday (10Jan2021) her stomach was hurting and she had a headache but no fever; but then yesterday (10Jan2021) her stomach was hurting and she had a headache but no fever; Got the vaccine early Friday afternoon and had a sore arm; This is a spontaneous report from a contactable consumer (patient) reported that a 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient got the vaccine early Friday (08Jan2021) afternoon and had a sore arm but then yesterday (10Jan2021) her stomach was hurting and she had a headache but no fever. The patient asked if that normal for side effects to occur 2 days later. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946041
Sex: F
Age:
State:

Vax Date: 12/23/2020
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: the anitbody test was negative; This is a spontaneous report from a contactable other healthcare professional reporting for herself. A female patient of unspecified age received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, on 23Dec2020 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was vaccinated with the Pfizer-BioNTech COVID-19 vaccine on 23Dec2020. She was given 1 of 2 shots. She then donated blood on 06Jan2021 but the anitbody test was negative. She was scheduled for 2nd vaccine on 13Jan2021. The patient asked when she would be expected to start building antibodies from the vaccine and how many weeks after the 2nd vaccine. She asked the estimated time span. Outcome of the event was unknown. Information on batch number has been requested.

Other Meds:

Current Illness:

ID: 0946042
Sex: F
Age:
State: OK

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Had change in smell; severe malaise; muscle aches with pain in injection site arm; muscle aches with pain in injection site arm; This is a spontaneous report from a Pfizer-sponsored program. A contactable other health professional (patient) reported that a female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number and Expiration Date unknown) via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications was not reported. On 18Dec2020 patient received first dose of Covid-19 vaccine. 24 hrs post vaccine on 19Dec2020, had severe malaise, muscle aches with pain in injection site arm. day 18 (05Jan2021), Had change in smell that she would describe as a foul burnt smell. No loss of smell or taste. Concerned that COVID-19 on day 21 (08Jan2021), had Covid-19 PCR that was non detectable. The outcome of events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946043
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain under her arm; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of unspecified age received the second dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. The patient received the second dose of the vaccine and noticed that the pain under her arm is still there. It started on Saturday 09Jan2021, and she was wondering how long that will persist. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946044
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slight swelling on the first dose; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of unspecified age received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had taken both doses of the Pfizer covid vaccine and did not experience any side effects like everybody else. She stated that she is concerned since everyone she had talked to who received the vaccine experienced some kind of side effects (fever, chills, body ache) and was wondering if the vaccine might not be working. She only experienced slight swelling on the first dose. Outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946045
Sex: F
Age:
State: DE

Vax Date: 01/08/2021
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; fatigue; diarrhea; swollen arm; red spot on her arm; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received the 2nd dose of the vaccine on 08Jan2021 and has had symptoms of headache, fatigue, diarrhea, swollen arm and a red spot on her arm. She is asking how long do these side effects usually last. Events outcome was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946046
Sex: F
Age:
State: KS

Vax Date: 12/17/2020
Onset Date: 12/29/2020
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: received first dose of bnt162b2/ symptoms started on the 26th (26Dec2020) but did not test positive until the 29th (29Dec2020); received first dose of bnt162b2/ symptoms started on the 26th (26Dec2020) but did not test positive until the 29th (29Dec2020); This is a spontaneous report from a Pfizer-sponsored program via a contactable nurse (patient). A 61-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number: VAC0002881; expiration date not provided), via an unspecified route of administration on 17Dec2020 at SINGLE DOSE for COVID-19 immunisation. Patient's medical history included hypothyroidism and osteoporosis from unknown dates, both ongoing. Concomitant medications included levothyroxine for hypothyroidism and alendronate sodium (FOSAMAX) for osteoporosis. Patient reported that her symptoms started on the 26th (26Dec2020) but did not test positive until the 29th (29Dec2020). Patient further stated "She received the first dose of Pfizer vaccine last 17Dec (17Dec2020) and 26Dec she was positive with COVID (later clarified of tested positive on 29Dec2020) because of someone else, it seems that it has been transferred, the virus has been transferred to her and then after a few days she got fully recovered, no symptoms, just fully recovered. She is just asking if she really need the second dose of vaccine if she is fully recovered right now." It was reported that patient did not receive treatment for the event. Laboratory test included COVID-19 virus test on 29Dec2020 with positive result. Outcome of the event was recovered.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.

Other Meds: ; FOSAMAX

Current Illness: Hypothyroidism; Osteoporosis

ID: 0946047
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Moderate allergic reaction; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) at a single dose, with route of administration and therapy date unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had moderate allergic reaction after the first dose of vaccination. The outcome of the event, moderate allergic reaction, was unknown. The patient was concerned if she should take the second dose. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946048
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching face, scalp and back; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) at a single dose, with route of administration and therapy dates unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had itching face, scalp and back. The outcome of the events, 'itching face, scalp and back', was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946049
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: coldness; numbness with extremities; sore throat; congested; shortness of breath; This is a spontaneous report from a non-contactable physician (patient). A 31-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on unknown date in Jan2021 at single dose for COVID-19 immunisation. The patient medical history and the concomitant medications were not reported. The patient received the second dose of the covid vaccine on Friday. The patient had coldness, numbness with extremities within 2 hours. She was not sure if it was just in her head. Saturday she had sore throat, was congested and had some shortness of breath. "Today" the patient was still congested and still with some shortness of breath, the patient wanted know if she should get tested for covid. The events were assessed non-serious. The was outcome was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0946050
Sex: U
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High platelets (over 1000; unit was not provided); This is a spontaneous report from a contactable healthcare professional. This healthcare professional reported similar events for two patients. This is the first of the two reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) at a single dose, with route of administration and therapy date unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had high platelets (over 1000; unit was not reported). The outcome of the event, high platelets, was unknown. Information on lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021022206 same reporter/drug/events, different patient

Other Meds:

Current Illness:

ID: 0946051
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu-like symptoms; body aches; low grade fever; didn't have the energy; This is a spontaneous report from a contactable Nurse. This female Nurse reported for herself received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 10:00 at single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. The patient woke up at midnight with flu-like symptoms and she was still having them in Jan2021. The body aches and low grade fever are the worst in Jan2021, enough that she called out of work. The patient just didn't have the energy in Jan2021. The outcome of didn't have the energy was unknown. The outcome of other events was not recovered. Information on the Lot/Batch Number has been requested.

Other Meds:

Current Illness:

ID: 0946052
Sex: F
Age:
State:

Vax Date: 12/28/2020
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt flushed; Elevated heart rate; This is a spontaneous report from a contactable nurse (patient). A 38-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 28Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient asked for some recommendations in taking the second dose of the vaccine since she had experienced the side effects- felt flushed and had elevated heart rate on an unspecified date. The outcome of the events was unknown. Information about the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0946053
Sex: F
Age:
State:

Vax Date: 12/21/2020
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: head cold; nose running; stuffy; sneeze; This is a spontaneous report from a contactable Nurse. This nurse (patient) reported that the (Age:59; Unit: Unknown) female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. The patient reported that "I got my first Covid vaccine on 21Dec. Today is three weeks and I am scheduled for my second shot. I have a head cold: nose running, stuffy, and I sneeze. I don't have Covid- I was tested and I'm negative. Its not my allergies. Its just a head cold. Can I get my second dose? No one can give me an answer." The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946054
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; muscle pain in the neck and back; cough; sneezing; dizziness; This is a spontaneous report from a contactable Nurse (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient got first dose of the vaccine this Saturday and is experiencing headache and muscle pain in the neck and back (main concerns), as well as cough, sneezing (starting to go away), and dizziness; all on Jan2021. She wants to know how long these will last. She was wondering if she can take Tylenol for these symptoms. Event outcome of sneezing was recovering, while for others was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946055
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a 13 week pregnant patient who received the first shot of the vaccine; lymphadenopathy; This is a spontaneous report from a contactable Physician via medical information team. A 13-week pregnant female patient of an unspecified age received first shot of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on an unspecified date at single dose, for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. Reporter was asking for any recommendations regarding the 2nd dose for a 13-week pregnant patient who received the first shot of the vaccine and developed lymphadenopathy a week after the 1st dose. She told that her gynecologist allowed her and gave her a note to take the 1st dose. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946056
Sex: F
Age:
State: LA

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date not provided), via an unspecified route of administration on an unspecified date at SINGLE DOSE for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. It was reported that patient's husband would like to know if Pfizer recommends use of acetaminophen to treat systemic side effects of the Covid vaccine due to possibility of blunted antibody response as it has been documented in the journal that this can occur, so he wanted to determine Pfizer's experience in relation to the Covid-19 vaccine. Patient's husband and patient received the vaccine yesterday (unspecified date) and were told that they could take APAP to treat systemic possible side effects. It was reported that the patient did develop a headache. Outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946057
Sex: M
Age:
State: LA

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching; bottom lip was swollen; This is a spontaneous report from a contactable consumer via the Medical Information Team. An 85-year-old male patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from an unspecified date at a single dose for an unspecified indication. Medical history included hard of hearing. The patient's concomitant medications were not reported. It was reported that the patient started itching and bottom lip was swollen. Bottom lip swelling has gone down today but she has still itching all over the body. She tried Benadryl but not helping. The outcome of the event itching was not recovered while recovering for the other event. Information about Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0946058
Sex: F
Age:
State: FL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experiencing pain in her back where kidneys; fatigued/extreme fatigue; dry cough; diarrhea; aches/pains/aches and pains around her body; severe pain in injection arm; injection site very painful; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 06Jan2021 at single dose for COVID-19 immunisation. The patient medical history and the concomitant medications were not reported. She reported that the evening of her first dose, she experienced severe pain in injection arm on 06Jan2021. She stated that night injection site very painful. She had to take Tylenol Extra Strength overnight. She stated that she woke up and she was fine. On 09Jan2021, she reported feeling fatigued, dry cough, extreme fatigue, diarrhea, aches/pains, and aches and pains around her body, but no fever. She woke up this morning on 11Jan2021, experiencing pain in her back where kidneys, still fatigued but no fever. She has taken the Covid test and does not have the results. She wanted to know if these are side effects of the vaccine or is this potentially the Covid virus. The events were assessed non-serious. The outcome of severe pain in injection arm, injection site very painful was recovered, of fatigued was not recovered, of other events were unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946059
Sex: F
Age:
State: NY

Vax Date: 01/09/2021
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: she takes an autoimmune suppressant, Tremfya, but did not disclose it when she got the vaccine; she takes an autoimmune suppressant, Tremfya, but did not disclose it when she got the vaccine; This is a spontaneous report from a contactable consumer via the Medical Information Team. A female patient of an unspecified age started to receive bnt162b2 (BNT162B2) , via an unspecified route of administration from 09Jan2021 to 09Jan2021 at a single dose for an unspecified indication; and guselkumab (TREMFYA), via an unspecified route of administration from 29Dec2020 to 29Dec2020 at an unspecified dose for an unspecified indication. Medical history included COVID from Mar2020. The patient's concomitant medications were not reported. It was reported that the patient got the first dose of Pfizer COVID-19 vaccine on Saturday 09Jan2021. She takes an autoimmune suppressant, Tremfya, but did not disclose it when she got the vaccine. The patient also reported to have a chest X-ray, an EKG, a stress echo test, and an MRI. Information on the lot/batch number has been requested.

Other Meds: TREMFYA

Current Illness:

ID: 0946060
Sex: U
Age:
State: LA

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: patient was last in the presence of a family member on Saturday (unspecified date) who two days later developed chills and fever and was diagnosed with the virus; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date not provided), via an unspecified route of administration on an unspecified date at SINGLE DOSE for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. It was reported that patient was given the COVID vaccine at work on an unspecified date and was due to take part two of the vaccine on Monday (unspecified date). However, it was reported that patient was last in the presence of a family member on Saturday (unspecified date) who two days later developed chills and fever and was diagnosed with the virus. Patient stated, "So, like I said two days after I left visiting this family member they developed it. I have no symptoms do I still take the vaccine on Monday as I am due to take it, part two of the vaccine?" Outcome of the event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0946061
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for Covid, 10 days after receiving the vaccine; Tested positive for Covid, 10 days after receiving the vaccine; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient tested positive for COVID on an unspecified date 10 days after receiving the vaccine. The patient underwent lab tests and procedures which included Covid test: positive on an unspecified date. The outcome of the events was unknown. The information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0946062
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm hurt; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer reported that a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. On unspecified date, the patient experienced arm hurt after getting it. Outcome of the event was unknown. Information about Lot/batch has been requested.

Other Meds:

Current Illness:

ID: 0946063
Sex: U
Age:
State: CA

Vax Date: 12/01/2020
Onset Date: 12/01/2020
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm was sore; hard to move without pain; This is a spontaneous report from a contactable nurse. A patient of an unspecified age and gender received first dose of BNT162B2 (Pfizer/ BioNTech Covid-19 vaccine) in dominant arm on an unspecified date in Dec2020 (approximate 24 days ago) at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Within hours that arm was sore and hard to move without pain. Patient could not get keys out of pocket without pain. Pain continued for 12 days. The outcome of the events was unknown. The patient received her second dose on 03Jan2021 in non dominant arm to avoid the lack of mobility. Information about Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0946064
Sex: F
Age:
State:

Vax Date: 12/23/2020
Onset Date: 12/01/2020
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen lymph nodes and headache after the first dose; swollen lymph nodes and headache after the first dose; This is a spontaneous report from a contactable other health professional (patient) from a Pfizer Sponsored Program Pfizer First Connect. A 27-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced swollen lymph nodes and headache on Dec2020. The patient outcome of the events was unknown. Information about Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 0946065
Sex: F
Age:
State: TX

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: broke out in a rash; This is a spontaneous report from a contactable consumer reporting for herself. A 68-year-old female patient received first dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on 08Jan2021, at a single dose for COVID-19 immunization. Medical history included chronic obstructive pulmonary disease (COPD) . She had many comorbidities including COPD. Concomitant medications were not reported. The patient broke out in a rash on 10Jan2021. She had a virtual HCP (healthcare professional) appointment and noticed it was on her face. Outcome of the event was unknown. Information on batch number has been requested.

Other Meds:

Current Illness:

ID: 0946066
Sex: M
Age:
State: WV

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizziness; he couldn't stand up; he laid down the bed would float; This is a spontaneous report from a contactable consumer (patient). An 81-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246, expiry: Apr2021), via an unspecified route of administration on 09Jan2021 11:45 at a single dose for COVID-19 immunization. Medical history included retired, he became allergic to penicillin when he was 17 year old and hasn't taken it since, lost his taste and smell, potassium is high sometimes - the doctor recommend he cut down on banana and potatoes, extra heart beat, stomach acid, and thyroid disorder. Ongoing concomitant medications included levothyroxine sodium - has been taking it for a year and a half to two years for thyroid, metoprolol succinate - has been on it about a year and half because an EKG showed he had an extra heart beat, and omeprazole capsule - been on it two or three years for stomach acid. The patient previously took trimethoprim/sulfamethoxazole (BACTRIM) and experienced allergy. After having a Pfizer shot on Saturday, he had a reaction - dizziness. His wife also received the COVID vaccine but did not have any reaction. He sat in the office for 15 minutes like he was supposed to. He drove home and was fine. Two hours later he was so dizzy he couldn't stand up. He was holding onto things to walk through the house. That was two hours after he took the vaccine. After that he thought it would go away in a day. All day yesterday, which was the second day, he was still dizzy. If he laid down the bed would float. It was an awful experience. He received the vaccine at 11:45am on 09Jan2021. Two hours later is when it started. He had to hold onto the rail to get up there. If he gets up quick it is still there. He just had blood work and was due back in Apr for check up. He hasn't had taste and smell for four years or better. He lost his taste and smell and never got it back. He doesn't know what caused that. He hasn't been sick. Outcome of the event dizziness was recovering, for the other events was unknown.

Other Meds: ; ;

Current Illness:

ID: 0946067
Sex: M
Age:
State:

Vax Date: 12/01/2020
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever went up 99.9; woke up covered in sweat; shaking so bad; shivering; had trouble keeping balance; swaying when walking; felt like crap; This is a spontaneous report from a contactable consumer. A 52-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Dec2020 at a single dose SINGLE DOSE for COVID-19 immunization. Medical history included COVID-19 in Apr2020. The patient's concomitant medications included celecoxib (CELEBREX). After receiving the vaccine fever went up 99.9, woke up covered in sweat, shaking so bad, shivering, had trouble keeping balance, was swaying when he was walking on an unspecified date. The patient also stated he felt ill for 3-4 days. The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds: CELEBREX

Current Illness:

ID: 0946068
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: has a little bit or arm pain and back pain on the side that she received the vaccine; has a little bit or arm pain and back pain on the side that she received the vaccine; This is a spontaneous report from a non-contactable consumer (caregiver). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration in arm, on an unspecified date, at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient recently received the vaccine and had a little bit of arm pain and back pain on the side that she received the vaccine on an unspecified date. The reported asked if this was normal and asked if the patient can use acetaminophen to treat pain and some warm compress. The outcome of the events was unknown. No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0946069
Sex: M
Age:
State: CT

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lymphedema; This is a spontaneous report received from a contactable other healthcare professional (who is also the patient). A male patient of an unspecified age (reported as 47, unit not provided, pending clarification) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration, on 08Jan2021, at single dose, for COVID-19 immunization, in the hospital. The patient's medical history and concomitant medications were not reported. The patient received his second dose of the COVID19 vaccine on Friday (08Jan2021) and experienced lymphedema as a side effect in Jan2021. The patient would like to know if there is anything he can do for it. The outcome of the event was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946070
Sex: F
Age:
State: IN

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: part of her trunk from the chest down started "itching really bad", and she developed hives; part of her trunk from the chest down started "itching really bad", and she developed hives; she still has a fine rash across the abdomen; there as 6 or 7 little macular spots; This is a spontaneous report from a contactable consumer reported for self. This female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 05Jan2021 at single dose for covid-19 immunisation. She had her first dose of the vaccine last Tuesday 05Jan2021. When at home in Jan2021, part of her trunk from the chest down started "itching really bad", and she developed hives. She took Benadryl, and the itching stopped, but she still has a fine rash across the abdomen, and the hives are still there as 6 or 7 little macular spots. Treatments for the events. Outcome of the event part of her trunk from the chest down started "itching really bad" was recovered in Jan2021. Outcome of the event hives, she still has a fine rash across the abdomen, there as 6 or 7 little macular spots was not recovered. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 662,381

Page last modified: 03 October 2021 5:28pm